drugset / Trial / NCT00001080

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

NCT00001080 ↗

Parallel-groupTreatment

Summary

To ascertain whether the origin of plasma HIV-1-RNA following T cell activation represents the activation of latently infected cells or an increase in cells permissive for replacing viral mutants. The mechanism by which immune stimulation increases circulating levels of HIV-1 is not known. In particular, it is uncertain whether the transient increase in plasma HIV-1 RNA is due to enhanced replication of an actively replicating pool of HIV-1, or is due instead to activation of proviral sequences in previously resting CD4+ cells. One approach to discriminate these alternatives is a "molecular pulse-chase" experiment. In this approach, drug resistant mutants would be selected by administration of Lamivudine (3TC).

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “as of 4/23/97”

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine — —
Subject Lamivudine Other / unclassified — —
Subject Pneumococcal Vaccine, Polyvalent (23-valent) Vaccine — —